Ultrasound-guided Block for Thoracic Surgery Pain

Sponsor
Samsung Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT03240562
Collaborator
(none)
89
1
2
4.9
18.2

Study Details

Study Description

Brief Summary

The investigators aimed to assess Ultrasounde- guided serratus anterior plane block can be effective in acute postoperative pain following thoracic surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: serratus anterior plane block
  • Drug: patient controlled analgesia
N/A

Detailed Description

Analgesic options for thoracotomy are various with each having their own merits and demerits.Thoracic epidural is said to be the gold standard for management of thoracotomy pain. However, it is invasive procedure and many side effects. Other options include paravertebral block, interpleural block, intrathecal opioids. Especially, paravertebral block is thought good alternative to epidural anethesia. Most of these invasive neuraxial techniques demand normal coagulation parameters to be present.

The serratus anterior plane block(SAPB) was done under ultrasound guidance in the mid-axillary line at the level of the fourth rib and the catheter was placed superficial to the serratus plane. The patient expressed relief in pain within 10 minutes of being given the bolus of local anaesthetic.Pain following thoracotomy is chiefly due to rib retraction, and damage to the serratus/intercostal muscles and intercostal nerves. A SAPB addresses both these aspects. SAPB has been mentioned in previous studies for management of rib fractures and breast surgeries. The investigators try to evaluate whether the SAPB is easy to perform and provides effective analgesia in patients undergoing thoracotomy with minimal side effects.

Study Design

Study Type:
Interventional
Actual Enrollment :
89 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Ultrasound-guided Serratus Anterior Plane Block for Thoracic Surgery Pain?
Actual Study Start Date :
Aug 3, 2017
Actual Primary Completion Date :
Nov 30, 2017
Actual Study Completion Date :
Dec 30, 2017

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: IV-PCA group

no block performing, only use intravenous patient controled analgesia(IV-PCA)

Drug: patient controlled analgesia
two groups have same intravenous patient controlled analgesia

Experimental: SAPB group

serratus anterior plane block(SAPB) and intravenous patient controled analgesia(IV-PCA)

Procedure: serratus anterior plane block
before surgery :ultrasound-guided serratus anterior plane block

Drug: patient controlled analgesia
two groups have same intravenous patient controlled analgesia

Outcome Measures

Primary Outcome Measures

  1. opioid consumption [the first 24hour in postoperative phase]

    the dose of PCA and residual opioid

Secondary Outcome Measures

  1. postoperative pain scale [intraoperative(immediately after surgery), postoperative 6 ,12, 24 hour]

    numeric rating scale

  2. opioid consumption [the first 6,12 hour in postoperative phase]

    the dose of PCA and residual opioid

Other Outcome Measures

  1. questionnaire about patient's satisfaction for pain management [postoperative 24 hour]

    score 1(bad)-5(good)

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

•undergoing thoracic surgery (lobectomy or segmentectomy)

Exclusion Criteria:

• allergy to any drugs chronic pain disease with medication psychologic disorder anti-depressant drug chronic kidney disease ( Cr over 2.0 mg/dl) coagulopathy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Samsung medical center Seoul Korea, Republic of 06351

Sponsors and Collaborators

  • Samsung Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT03240562
Other Study ID Numbers:
  • SMC2017-06-123
First Posted:
Aug 7, 2017
Last Update Posted:
Feb 28, 2018
Last Verified:
Jul 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Samsung Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 28, 2018